Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Ida Maiorino

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 14, 2014
Diabetes and sexual dysfunction: current perspectivesMaria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Asian Journal of Andrology|September 25, 2014
Lifestyle modifications and erectile dysfunction: what can be expected?Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Cardiovascular Diabetology|February 6, 2021
The residual cardiorenal risk in type 2 diabetesDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|June 5, 2017
Particulate matter air pollution: individual choices for improving cardiometabolic well-beingKatherine Esposito, Giuseppe Bellastella, Maria Ida Maiorino, et al.
Endocrine|March 21, 2018
More sugar? No, thank you! The elusive nature of low carbohydrate dietsDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|March 23, 2016
Premixed insulin regimens in type 2 diabetes: prosMaria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito, et al.
Endocrine|May 29, 2017
Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and consMaria Ida Maiorino, Michela Petrizzo, Giuseppe Bellastella, et al.
Endocrine|September 13, 2017
Type 2 diabetes and cardiovascular prevention: the dogmas disputedDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|May 26, 2016
Glucose, cholesterol, and blood pressure: is lower always better for type 2 diabetes?Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|May 28, 2016
Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 14, 2014
Diabetes and sexual dysfunction: current perspectivesMaria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Asian Journal of Andrology|September 25, 2014
Lifestyle modifications and erectile dysfunction: what can be expected?Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Cardiovascular Diabetology|February 6, 2021
The residual cardiorenal risk in type 2 diabetesDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|June 5, 2017
Particulate matter air pollution: individual choices for improving cardiometabolic well-beingKatherine Esposito, Giuseppe Bellastella, Maria Ida Maiorino, et al.
Endocrine|March 21, 2018
More sugar? No, thank you! The elusive nature of low carbohydrate dietsDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|March 23, 2016
Premixed insulin regimens in type 2 diabetes: prosMaria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito, et al.
Endocrine|May 29, 2017
Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and consMaria Ida Maiorino, Michela Petrizzo, Giuseppe Bellastella, et al.
Endocrine|September 13, 2017
Type 2 diabetes and cardiovascular prevention: the dogmas disputedDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|May 26, 2016
Glucose, cholesterol, and blood pressure: is lower always better for type 2 diabetes?Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Endocrine|May 28, 2016
Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, et al.
Pageof 16